Stay updated on Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Sign up to get notified when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.

Latest updates to the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedAn NIH-wide notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the clinical trial record content.SummaryDifference0.8%

- Check31 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check59 days agoChange DetectedThe record history adds a new revision entry 'Revision: v3.7.0' and removes the previous 'Revision: v3.6.6', signaling an update to the study record history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now includes a new latest revision labeled v3.6.6, indicating a more recent update to the page. The older revision labeled v3.6.5 has been removed from the visible history.SummaryDifference0.1%

Stay in the know with updates to Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.